Journal of Isfahan Dental School

Glypican-3 Expression in Dentigerous Cyst, Odontogenic Keratocyst and Radicular Cyst

Document Type : مقاله‌های پژوهشی

Authors

1 Associate Professor, Oral and Dental Disease Research Center, Department of Oral and Maxillofacial Pathology, School of Dentistry, Shiraz University of Medical Sciences, Shiraz, Iran.

2 Undergraduate Student, School of Dentistry, Shiraz University of Medical Sciences, Shiraz, Iran.

3 Assistant Professor, Department of oral and Maxillofacial Pathology, School of Dentistry, Shiraz University of Medical Sciences, Shiraz, Iran.

Abstract

Introduction: Glypican-3 is a cell surface protein, a member of glypican family and belongs to a group of heparin sulfate proteoglycan bound to the cell membrane through a glycosyl-phosphatidyl inositol anchor. GPC3 is involved in the regulation of cell proliferation and morphogenesis. Considering the distinct clinical behavior of odontogenic lesions, the aim of the present study was to investigate the immunohistochemical expression of GPC3 in dentigerous cyst, odontogenic keratocyst and radicular cyst.
Materials & Methods: In this descriptive, retrospective, cross-sectional study, 60 tissue samples of odontogenic cysts consist of 20 radicular cysts (RC), 20 odontogenic keratocysts (OKC) and 20 dentigerous cysts (DC) were reviewed by immunohistochemistry staining for GPC3 marker.
Results: In this study, both membranous and cytoplasmic expression of glypican-3 was observed. GPC3 expression was seen in 60% of OKCs (12/20). No GPC3 immunoreactivity was seen in DCs and RCs.
Conclusion: A high expression rate of GPC3 was detected in OKC, which might be related to the aggressive behavior and high recurrence rate of OKC; however, further studies are necessary to confirm this hypothesis.
Key words: Dentigerous cyst, Glypican-3, Odontogenic keratocyst, Radicular cyst.

1. Filmus J, Selleck SB. Glypicans: proteoglycans with a surprise. J Clin Invest 2001; 108(4): 497-501.
2. Wang F, Jing X, Wang T, Li G, Li T, Zhang Q, et al. Differential diagnostic value of GPC3-CD34 combined staining in small liver nodules with diameter less than 3 cm. Am J Clin Pathol 2012; 137(6): 937-45.
3. Grozdanov PN, Yovchev MI, Dabeva MD. The oncofetal protein glypican-3 is a novel marker of hepatic progenitor/oval cells. Lab Invest 2006; 86(12): 1272-84.
4. Midorikawa Y, Ishikawa S, Iwanari H, Imamura T, Sakamoto H, Miyazono K, et al. Glypican-3, overexpressed in hepatocellular carcinoma, modulates FGF2 and BMP-7 signaling. Int J Cancer 2003; 103(4): 455-65.
5. Nakatsura T, Kageshita T, Ito S, Wakamatsu K, Monji M, Ikuta Y, et al. Identification of glypican-3 as a novel tumor marker for melanoma. Clinical Cancer Research 2004; 10(19): 6612-21.
6. Baumhoer D, Tornillo L, Stadlmann S, Roncalli M, Diamantis EK, Terracciano LM. Glypican 3 expression in human nonneoplastic, preneoplastic, and neoplastic tissues: a tissue microarray analysis of 4,387 tissue samples. Am J Clin Pathol 2008; 129(6): 899-906.
7. He H, Fang W, Liu X, Weiss LM, Chu PG. Frequent expression of glypican-3 in Merkel cell carcinoma: an immunohistochemical study of 55 cases. Appl Immunohistochem Mol Morphol 2009; 17(1): 40-6.
8. Andisheh-Tadbir A, Gorgizadeh A. CD166 expression in dentigerous cyst, keratocystic odontogenic tumor and ameloblastoma. J Clin Exp Dent 2016; 8(3): e236-e240.
9. Andisheh-Tadbir A, Fakharian M. HSP70 expression in dentigerous cyst, odontogenic keratocyst, and ameloblastoma. Oral Maxillofac Surg 2015; 19(3): 287-91.
10. Pechalova PF, Bakardjiev AG. Cysts of the Jaws: a clinical study of 621 cases. Acta Stomatol Croat 2009; 43(3): 215-24.
11. Ilan N, Elkin M, Vlodavsky I. Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis. Int J Biochem Cell Biol 2006; 38(12): 2018-39.
12. Gonzalez‐Alva P, Tanaka A, Oku Y, Miyazaki Y, Okamoto E, Fujinami M, et al. Enhanced expression of podoplanin in ameloblastomas. J Oral Pathol Med 2010; 39(1): 103-9.
13. Barnes L, Eveson JW, Reichart P, Sidransky D. World Health Organization classification of tumours: pathology and genetics of head and neck tumours. Lyon, France: IARC Press; 2005.
14. Tsuneki M, Cheng J, Maruyama S, Ida‐Yonemochi H, Nakajima M, Saku T. Perlecan‐rich epithelial linings as a background of proliferative potentials of keratocystic odontogenic tumor. J Oral Pathol Med 2008; 37(5): 287-93.
15. Khan S, Blackburn M, Mao DL, Huber R, Schlessinger D, Fant M. Glypican-3 (GPC3) expression in human placenta: localization to the differentiated syncytiotrophoblast. Histol Histopathol. 2001; 16(1): 71-8.
16. Pellegrini M, Pilia G, Pantano S, Lucchini F, Uda M, Fumi M, et al. Gpc3 expression correlates with the phenotype of the Simpson-Golabi-Behmel syndrome. Dev Dyn 1998; 213(4): 431-9.
17. Gonzalez AD, Kaya M, Shi W, Song H, Testa JR, Penn LZ, et al. OCI-5/GPC3, a glypican encoded by a gene that is mutated in the Simpson-Golabi-Behmel overgrowth syndrome, induces apoptosis in a cell line-specific manner. J Cell Biol 1998; 141(6): 1407-14.
18. Kim H, Xu GL, Borczuk AC, Busch S, Filmus J, Capurro M, et al. The heparan sulfate proteoglycan GPC3 is a potential lung tumor suppressor. Am J Respir Cell Mol Biol 2003; 29(6): 694-701.
19. Valsechi MC, Oliveira ABB, Conceição ALG, Stuqui B, Candido NM, Provazzi PJS, et al. GPC3 reduces cell proliferation in renal carcinoma cell lines. BMC Cancer 2014; 14(1): 631.
20. Stadlmann S, Gueth U, Baumhoer D, Moch H, Terracciano L, Singer G. Glypican-3 expression in primary and recurrent ovarian carcinomas. Int J Gynecol Pathol 2007; 26(3): 341-4.
21. Li YS, Milner PG, Chauhan AK, Watson MA, Hoffman RM, Kodner CM, et al. Cloning and expression of a developmentally regulated protein that induces mitogenic and neurite outgrowth activity. Science 1990; 250(4988): 1690-4.
22. Aviel-Ronen S, Lau SK, Pintilie M, Lau D, Liu N, Tsao MS, et al. Glypican-3 is overexpressed in lung squamous cell carcinoma, but not in adenocarcinoma. Mod Pathol 2008; 21(7): 817-25.
23. Ho M, Kim H. Glypican: 3-a new target for cancer immunotherapy. Eur J Cancer 2011; 47(3): 333-8.
24. Song HH, Shi W, Xiang YY, Filmus J. The loss of glypican 3-induces alterations in Wnt signaling. J Biol Chem 2005; 280(3): 2116-25.
25. Capurro MI, Xiang YY, Lobe C, Filmus J. Glypican-3 promotes the growth of hepatocellular carcinoma by stimulating canonical Wnt signaling. Cancer Res 2005; 65(14): 6245-54.
26. Capurro MI, Xu P, Shi W, Li F, Jia A, Filmus J. Glypican-3 inhibits Hedgehog signaling during development by competing with patched for Hedgehog binding. Dev Cell 2008; 14(5): 700-11.
27. Qi XH, Wu D, Cui HX, Ma N, Su J, Wang YT, et al. Silencing of the glypican-3 gene affects the biological behavior of human hepatocellular carcinoma cells. Mol Med Rep 2014; 10(6): 3177-84.
28. Tanaka SS, Kojima Y, Yamaguchi YL, Nishinakamura R, Tam PP. Impact of WNT signaling on tissue lineage differentiation in the early mouse embryo. Dev Growth Differ 2011; 53(7): 843-56.
29. Gao W, Ho M. The role of glypican-3 in regulating Wnt in hepatocellular carcinomas. Cancer Rep 2011; 1(1): 14-19.
30. Shimada Y, Katsube K, Kabasawa Y, Morita K, Omura K, Yamaguchi A, et al. Integrated genotypic analysis of hedgehog-related genes identifies subgroups of keratocystic odontogenic tumor with distinct clinicopathological features. PLoS ONE 2013; 8(8): e70995.
31. Capurro M, Wanless IR, Sherman M, Deboer G, Shi W, Miyoshi E, et al. Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma. Gastroenterology 2003; 125(1): 89-97.
Journal of Isfahan Dental School
Volume 14, Issue 3 - Serial Number 3
July 2018
Pages 305-312